Recent Advances and Challenges in Controlling the Spatiotemporal Release of Combinatorial Anticancer Drugs from...

Area of Science:

• Oncology
• Nanotechnology
• Drug Delivery Systems

Background:

• Chemotherapy remains a cornerstone of cancer treatment, with ongoing research exploring novel delivery systems.
• Nano-formulated combinatorial drugs (NFCDs) integrate nanoparticle carriers with multi-drug therapies for enhanced efficacy.
• NFCDs leverage nanotechnology for drug stability, targeted delivery to cancer cells, and synergistic therapeutic effects.

Purpose of the Study:

• To review recent advancements in controlling the spatiotemporal release of drugs from NFCDs.
• To classify combinatorial drug release strategies based on temporal and spatial parameters.
• To detail the programming techniques enabling controlled drug release from NFCDs.

Main Methods:

• Classification of NFCDs based on drug release profiles (temporal and spatial).
• Description of nanotechnology-based programming techniques for controlled drug release.
• Analysis of the impact of drug release timing and location on anticancer outcomes.

Main Results:

• NFCDs enable precise control over drug release kinetics and localization.
• Spatiotemporal control is achieved through nanotechnology and specific drug combinations.
• Varied release patterns demonstrate significant potential for enhanced anticancer efficacy.

Conclusions:

• Controlled spatiotemporal drug release from NFCDs is crucial for optimizing cancer therapy.
• Advances in nanotechnology offer sophisticated methods for programming drug release.
• Tailoring drug release profiles can significantly improve therapeutic outcomes and reduce side effects.